The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-man trial of 4-(N-(S-penicillaminylacetyl)amino) phenylarsonous acid (PENAO) as a continuous intravenous infusion (CIVI), in patients (pt) with advanced solid tumours.
 
Ben Tran
Honoraria - Astellas Pharma; Janssen-Cilag; Sanofi; Tolmar
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Sanofi; Tolmar
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Genentech (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma
 
Anne L. Hamilton
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst)
 
Lisa Horvath
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Lilly; Pfizer; Roche
 
Michael Lam
No Relationships to Disclose
 
Peter Stephen Savas
No Relationships to Disclose
 
Peter S. Grimison
Travel, Accommodations, Expenses - IPSEN
 
James R. Whittle
No Relationships to Disclose
 
James Chun-Yen Kuo
No Relationships to Disclose
 
Nicole Signal
No Relationships to Disclose
 
David Edmonds
No Relationships to Disclose
 
Philip J Hogg
No Relationships to Disclose
 
Danny Rischin
Research Funding - Genentech/Roche; Merck; Threshold Pharmaceuticals
 
Jayesh Desai
No Relationships to Disclose